Your enterprise runs on data, but only inside drives results.
With Adverity, data analytics become effortless and intelligent.
Bring all your data together.
Uncover hidden patterns and let AI inform your decisions.
Ask in plain English and get answers that drive smarter action across your business.
Enterprise Scale, Enterprise Security.
Adverity, from data to intelligent action.
Visit Adverity.com and book your demo today.
Good morning from the Financial Times.
Today is Tuesday, November 4th, and this is your FT News briefing.
Palantir continues to ride high,
and two drugmakers are going head-to-head and getting the courts involved.
In Farmerland right now, investors really only care about one thing, which is,
do you have a weight loss drug, or do you have a next generation weight loss drug?
Plus, China is trying to get countries to ditch the US dollar, and the White House is pushing back.
I'm Mark Filipino, and here's the news you need to start your day.
The good times keep on rolling for Palantir.
The data intelligence company boosted its sales guidance for 2025 yesterday.
The projection went from a little more than $4 billion to $4.4 billion,
which is more than what Wall Street was expecting.